Switch to:
More From Other Websites
Alexion's (ALXN) Soliris Gets Orphan Drug Status in Japan Nov 26 2014
6:32 am Alexion Pharma announced that Soliris has been granted orphan drug designation by Japan's... Nov 25 2014
Soliris® (eculizumab) Granted Orphan Drug Designation in Japan for the Treatment of Patients with... Nov 25 2014
Has Alexion Pharmaceuticals Healed From Its Bad Break? Nov 20 2014
Are consumers getting gouged on health care? Nov 18 2014
Here Are Some Big Caps Poised To Make Gains Nov 17 2014
Longer-term Outcome Data from the Largest Prospective Trial of Soliris® (eculizumab) in aHUS... Nov 15 2014
Longer-term Outcome Data from the Largest Prospective Trial of Soliris® (eculizumab) in aHUS... Nov 15 2014
Alexion, EA: Two Top Stocks Form Good Chart Patterns Nov 14 2014
Taking Stock: Iqbal Favors Oil, Transportation, Health Care Nov 14 2014
Big Cap 20 Stuffed With Medical Names Nov 10 2014
ALEXION PHARMACEUTICALS INC Files SEC form 8-K, Change in Directors or Principal Officers, Financial... Nov 10 2014
Alexion Pharma co-founder Squinto to retire Nov 10 2014
Alexion Pharma co-founder Squinto to retire Nov 10 2014
Alexion Announces Planned Retirement of Stephen Squinto, Ph.D., Company Co-Founder and Chief Global... Nov 10 2014
Alexion Announces Planned Retirement of Stephen Squinto, Ph.D., Company Co-Founder and Chief Global... Nov 10 2014
Researchers to Present Data on Improving the Understanding of PNH and aHUS and Underscoring the... Nov 06 2014
Top Funds Buy Ulta Beauty, Alexion, Avago Nov 04 2014
Big Cap 20: Health Care, Tech Stocks Rule The Roost Nov 03 2014
ALEXION PHARMACEUTICALS INC Financials Oct 31 2014


Add Notes, Comments

If you want to ask a question, or report a bug, please create a support ticket.

User Comments

No comment yet


Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Free 7-day Trial
FEEDBACK